Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
LI
Ethos Technologies Inc. Class A Common Stock
LIFE
Mkt Cap
$2.44B
Volume
1.03M
Next Earnings
November 2nd
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
LI
LIFE
LI
Ethos Technologies Inc. Class A Common Stock
LIFE
News
·
Ethos Chief Underwriter Nichole Myers Shares Why So Many Americans Are Still Waiting to Get Life Insurance on YourUpdateTV
Mkt Cap
$2.44B
Volume
1.03M
Next Earnings
November 2nd
Chart
Financials
Earnings
News
About
Insider
Filings
Ethos Chief Underwriter Nichole Myers Shares Why So Many Americans Are Still Waiting to Get Life Insurance on YourUpdateTV
Ethos research reveals that 72% of Americans wish they had purchased life insurance sooner, with 70% knowing they needed it before acting. The primary barrier is misconception about cost, though a healthy 30-year-old can obtain meaningful coverage for approximately $1 per day. Ethos has streamlined the application process to under 10 minutes online without medical exams, addressing historical delays of 6-8 weeks.
GlobeNewswire Inc. · Sep 4, 2026
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
GlobeNewswire Inc. · Jun 3, 2024
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc. · May 24, 2024
Wall Street Breakfast: The Week Ahead
This article highlights upcoming events in the financial world, including quarterly earnings reports, IPOs, investor events, and market volatility updates.
Seeking Alpha · May 19, 2024
aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
GlobeNewswire Inc. · May 15, 2024
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
GlobeNewswire Inc. · May 14, 2024
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
aTyr Pharma announces first quarter 2024 results and provides corporate update
GlobeNewswire Inc. · May 2, 2024
aTyr Pharma to Participate in April Investor Conferences
aTyr Pharma to Participate in April Investor Conferences
GlobeNewswire Inc. · Apr 1, 2024
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
GlobeNewswire Inc. · Mar 14, 2024
Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates
Editas (EDIT) delivered earnings and revenue surprises of 55.77% and 347.63%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · Feb 28, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
LI
LIFE
Ethos Technologies Inc. Class A Common Stock
Buy
Sell
Market
Limit
Soon
LIFE
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any LIFE yet.
Related Tickers
Earnings